Hyliion stock faces intense selling pressure after a research report challenged the validity of $133 million in projected pipeline revenue, citing concerns over the counterparty's operational capacity.
Hyliion shares fell 33% after a research report alleged a counterparty behind $133 million of projected pipeline revenue was a four-employee company incorporated five months earlier, and a securities class action deadline is approaching.
Hyliion Holdings Corp. shares plummeted 33% over two sessions following a critical research report. The report questioned the legitimacy of a counterparty linked to $133 million in projected pipeline revenue, alleging the firm was a small, recently incorporated entity.
The stock declined 33% after a research report questioned the credibility of a counterparty responsible for $133 million of the company's projected pipeline revenue.